Icariin inhibits chondrocyte ferroptosis and alleviates osteoarthritis by enhancing the SLC7A11/GPX4 signaling
Top Cited Papers
Open Access
- 17 April 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 133, 112010
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Targeting regulated chondrocyte death in osteoarthritis therapyBiochemical Pharmacology, 2023
- Uncovering the IL‐1β‐PCAF‐NNT axis: A new player in ferroptosis and tumor immune evasionCancer Communications, 2023
- The Effect of JAK Inhibitor Tofacitinib on Chondrocyte AutophagyInflammation, 2023
- Inhibition of ferroptosis by icariin treatment attenuates excessive ethanol consumption-induced atrial remodeling and susceptibility to atrial fibrillation, role of SIRT1Apoptosis, 2023
- Icariin: A Potential Neuroprotective Agent in Alzheimer’s Disease and Parkinson’s DiseaseNeurochemical Research, 2022
- Prevalence Trends of Site‐Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019Arthritis & Rheumatology, 2022
- Iron homeostasis in arthropathies: From pathogenesis to therapeutic potentialAgeing Research Reviews, 2021
- Diagnosis and Treatment of Hip and Knee OsteoarthritisJAMA, 2021
- Pharmacological effects of icariin2020
- Aging and osteoarthritis: Central role of the extracellular matrixAgeing Research Reviews, 2017